2014
DOI: 10.1021/jm5004914
|View full text |Cite
|
Sign up to set email alerts
|

Ligand-Based Pharmacophore Modeling and Virtual Screening for the Discovery of Novel 17β-Hydroxysteroid Dehydrogenase 2 Inhibitors

Abstract: 17β-Hydroxysteroid dehydrogenase 2 (17β-HSD2) catalyzes the inactivation of estradiol into estrone. This enzyme is expressed only in a few tissues, and therefore its inhibition is considered as a treatment option for osteoporosis to ameliorate estrogen deficiency. In this study, ligand-based pharmacophore models for 17β-HSD2 inhibitors were constructed and employed for virtual screening. From the virtual screening hits, 29 substances were evaluated in vitro for 17β-HSD2 inhibition. Seven compounds inhibited 17… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
44
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(44 citation statements)
references
References 67 publications
0
44
0
Order By: Relevance
“…However, there are no defined standards for precision (hit rate) and recall (yield) values of pharmacophore based virtual screening, multiple studies have been done to evaluate designed pharmacophores 51–53,5758. For example, a study on ligand‐based pharmacophore models for discovery of 17β‐Hydroxysteroid Dehydroxygenase 2 inhibitors57 reported hit rate of 24 to 50 % and yield of 40 to 50 %; and another screening by receptor based pharmacophore models designed for HIV‐1 protease inhibitors58 also reported their hit rates (10 to 36 %) and yield values (0.7 to 4.5 %). The hit rates for our pharmacophore models can be summarized as hit rates of 89 to 93 % and yield values of 19 to 20 %.…”
Section: Resultsmentioning
confidence: 99%
“…However, there are no defined standards for precision (hit rate) and recall (yield) values of pharmacophore based virtual screening, multiple studies have been done to evaluate designed pharmacophores 51–53,5758. For example, a study on ligand‐based pharmacophore models for discovery of 17β‐Hydroxysteroid Dehydroxygenase 2 inhibitors57 reported hit rate of 24 to 50 % and yield of 40 to 50 %; and another screening by receptor based pharmacophore models designed for HIV‐1 protease inhibitors58 also reported their hit rates (10 to 36 %) and yield values (0.7 to 4.5 %). The hit rates for our pharmacophore models can be summarized as hit rates of 89 to 93 % and yield values of 19 to 20 %.…”
Section: Resultsmentioning
confidence: 99%
“…This Pharmacophore model was used as 3D query for searching out the matching pharmacophore Hits from diverse databases [DrugBank, MDPI, ZINC, Maybridge HitFinder]. 29,30,32,44,45 The model was represented in Figure 2.…”
Section: The Generation Of the Ligand-based Pharmacophore Modelmentioning
confidence: 99%
“…[11][12][13][14] Recently, a combined screening strategy of pharmacophore mapping and molecular docking show synergetic effect in virtual screening. 15,16 As such, the integrally globally and partially essential pharmacophoric features for both of ligand and receptor can be simultaneously characterized, thereby showing more preferable performance (e.g.…”
Section: -10mentioning
confidence: 99%